Professor Paul Glue's research focuses on clinical and basic science to investigate the pharmacology of drug treatments in psychiatry and the disease mechanisms of neurological and psychiatric disorders. He is also interested in psychopharmacology and the development of novel therapeutics for affective disorders. Biomarkers for anxiety and the technical aspects of clinical trial design, including trialing simulation and modeling are other areas of interest. He has published extensively, with more than 300 papers, book chapters and abstracts to his name.
Find out more about Professor Paul Glue's research
Publications
Wang, D., Jackson, C., Hung, N., Hung, T., Kwan, R., Chan, W.-K., … Hughes-Medlicott, N. J., Glue, P., & Duffull, S. (2024). Oral docetaxel plus encequidar: A pharmacokinetic model and evaluation against IV docetaxel. Journal of Pharmacokinetics & Pharmacodynamics. Advance online publication. doi: 10.1007/s10928-024-09913-y Journal - Research Article
Martin, D. M., Harvey, A. J., Baune, B., Berk, M., Carter, G. L., Dong, V., … Glue, P., … Loo, C. K. (2024). Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS). Journal of Affective Disorders, 352, 163-170. doi: 10.1016/j.jad.2024.02.052 Journal - Research Article
Glue, P., Neehoff, S., Beaglehole, B., Shadli, S., McNaughton, N., & Hughes-Medlicott, N. J. (2024). Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study. Journal of Psychopharmacology, 38(2), 162-167. doi: 10.1177/02698811241227026 Journal - Research Article
Taube, C., Mentzel, C., Glue, P., & Barak, Y. (2024). Aging of persons with schizophrenia: Analysis of a national dataset. International Psychogeriatrics, 36(1), 43-50. doi: 10.1017/S1041610223000145 Journal - Research Article
Kemp, A., Harrison, O., Russell, B., & Glue, P. (2023). Using neuroimaging to investigate functional connectivity alterations associated with anxiety. Proceedings of the Psycolloquy Symposium. (pp. 29). Dunedin, New Zealand: Department of Psychology, University of Otago. Retrieved from https://www.otago.ac.nz/psychology/research/otago059081.html Conference Contribution - Published proceedings: Abstract
Anderson, L., De Ridder, D., Glue, P., Mani, R., & Adhia, D. (2023). Exploring novel effective connectivity neurofeedback training for treatment of fibromyalgia: A pilot randomised placebo-controlled study. In T. Milne, M. Anwar, L. Burga, H. Harcombe, M. Garelja, A. Middleton, D. C. Ribeiro, N. Fleming, K. Ogbuehi & A. Bahn (Eds.), Proceedings of the 268th Otago Medical School Research Society (OMSRS) Meeting: Masters/Honours/Postgraduate Diploma Student Speaker Awards. Dunedin, New Zealand: OMSRS. Retrieved from https://ourarchive.otago.ac.nz/handle/10523/12839 Conference Contribution - Published proceedings: Abstract
Turner, R., Glue, P., & Barak, Y. (2023). The interRAI assessment for elder abuse: We can do better? Lessons from the Elder Abuse Prevention Fund project in New Zealand. Proceedings of the New Zealand Biostatistics Conference. Retrieved from https://events.otago.ac.nz/2023-biostatistics-conference Conference Contribution - Published proceedings: Abstract
Beaglehole, B., Glue, P., Clarke, M., & Porter, R. (2023). Multidisciplinary development of guidelines for ketamine treatment for treatment-resistant major depression disorder for use by adult specialist mental health services in New Zealand. BJPsych Open, 9, e191. doi: 10.1192/bjo.2023.577 Journal - Research Other
Crellin, S., Sheard, P., Heyward, P. M., De Ridder, D., & Glue, P. (2023). Modulation of axonal action potential conduction with bipolar disorder therapeutics. In K.-L. Horne (Ed.), Proceedings of the 39th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 48). Retrieved from https://www.awcbr.org Conference Contribution - Published proceedings: Abstract
van Sleeuwen, C., Adhia, D., Glue, P., Hall, M., & De Ridder, D. (2023). High-definition transcranial grey noise stimulation (HD-tGNS) as an intervention for generalized anxiety disorder: A pilot randomised sham-controlled trial. In K.-L. Horne (Ed.), Proceedings of the 39th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 41). Retrieved from https://www.awcbr.org Conference Contribution - Published proceedings: Abstract
Anderson, L., De Ridder, D., Glue, P., Mani, R., & Adhia, D. (2023). Exploring novel functional connectivity neurofeedback training for treatment of fibromyalgia: A pilot randomised placebo-controlled study. In K.-L. Horne (Ed.), Proceedings of the 39th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 26). Retrieved from https://www.awcbr.org Conference Contribution - Published proceedings: Abstract
Wang, D., Hung, T., Hung, N., Glue, P., Jackson, C., & Duffull, S. (2023). Optimal sample selection applied to information rich, dense data. Journal of Pharmacokinetics & Pharmacodynamics. Advance online publication. doi: 10.1007/s10928-023-09883-7 Journal - Research Other
Loo, C., Glozier, N., Barton, D., Baune, B. T., Mills, N. T., Fitzgerald, P., Glue, P., … Rodgers, A. (2023). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): Randomised double-blind active-controlled trial. British Journal of Psychiatry. Advance online publication. doi: 10.1192/bjp.2023.79 Journal - Research Article
Barak, Y., Taube, C., Mentzel, C., & Glue, P. (2023). Ageing of persons with schizophrenia: Analysis of a national data set. Australian & New Zealand Journal of Psychiatry, 57(Suppl. 1), (pp. 165). doi: 10.1177/00048674231169682 Conference Contribution - Published proceedings: Abstract
Potiki, J., Tawaroa, D., Casey, H., Thom, K., O'Brien, A., Lenagh-Glue, J., & Glue, P. (2023). Cultural influences on the creation and use of psychiatric advance directives. Psychiatric Services, 74(12), 1299-1302. doi: 10.1176/appi.ps.20220565 Journal - Research Article
Glue, P., & McNaughton, N. (2023). Why doesn't adjunctive ketamine enhance ECT's antidepressant efficacy in major depressive disorder: influence of ketamine dose. Psychiatry Research Case Reports. Advance online publication. doi: 10.1016/j.psycr.2023.100137 Journal - Research Article
Kew, B. M., Porter, R. J., Douglas, K. M., Glue, P., Mentzel, C. L., & Beaglehole, B. (2023). Ketamine and psychotherapy for the treatment of psychiatric disorders: Systematic review. BJPsych Open, 9, e79. doi: 10.1192/bjo.2023.53 Journal - Research Other
Lin, X. I., White, T., Gray, A. R., & Glue, P. (2023). The short- to medium-term predictive validity of the HoNOS-Secure on violence in a medium-secure forensic psychiatric ward in New Zealand. Journal of Forensic Psychiatry & Psychology, 34(2), 149-165. doi: 10.1080/14789949.2023.2189150 Journal - Research Article
Mentzel, C., Taube, C., Glue, P., & Barak, Y. (2023). Older adults with schizophrenia and dementia: Analysis of a national dataset [Brief report]. Australasian Journal on Ageing, 42, 609-612. doi: 10.1111/ajag.13187 Journal - Research Other
Mentzel, C., Glue, P., Greco, P., & Barak, Y. (2023). Analysing realistic effects of modifiable risk factors for dementia in a large national dataset. Archives of Gerontology & Geriatrics, 105, 104852. doi: 10.1016/j.archger.2022.104852 Journal - Research Article
Barak, Y., Greco, P., & Glue, P. (2023). Aging among persons with serious mental illness: Policy implications for earlier onset of frailty. GeroPsyc, 36(2), 92-96. doi: 10.1024/1662-9647/a000302 Journal - Research Article
Stegmann, B., Gale, C., & Glue, P. (2023). Maintenance ECT treatment in New Zealand: Local and national data. Australasian Psychiatry, 31(1), 90-94. doi: 10.1177/10398562221126589 Journal - Research Article
Lenagh-Glue, J., Dawson, J., Potiki, J., O'Brien, A. J., Thom, K., Casey, H., & Glue, P. (2023). Use of advance directives to promote supported decision-making in mental health care: Implications of international trends for reform in New Zealand. Australian & New Zealand Journal of Psychiatry, 57(5), 636-641. doi: 10.1177/00048674221079225 Journal - Research Other
Glue, P. (2022, November). Three research areas. Verbal presentation at the Department of Psychological Medicine Research Day, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Perez, T. M., Glue, P., Adhia, D. B., Navid, M. S., Zeng, J., Dillingham, P., … Young, C. K., & De Ridder, D. (2022). Infraslow closed-loop brain training for anxiety and depression (ISAD): A protocol for a randomized, double-blind, sham-controlled pilot trial in adult females with internalizing disorders. Trials, 23, 949. doi: 10.1186/s13063-022-06863-z Journal - Research Other
Kemp, A., Pattinson, K., Glue, P., Russell, B., & Harrison, O. (2022, September). Assessing the relationship between sub-clinical anxiety and resting state functional connectivity. Verbal presentation at the Postgraduate & Early Career Researchers Committee (PERC) & Division of Health Sciences Early & Mid-Career Researcher (EMCR) Joint Research Symposium, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P., English, S., Hoeh, N., & Mentzel, C. (2022, September). Current ketamine research in Australasia: Indications, assisted psychotherapy, and use of new formulations. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Menkes, D., Glue, P., Billingsley, M., Sawers, N., Murphy, R., Miller, E., … Evans, W. (2022, September). Psychedelic medicines in New Zealand: Current research and future prospects. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Kemp, A., Pattinson, K., Glue, P., Russell, B., & Harrison, O. (2022). Assessing the relationship between sub-clinical anxiety and resting state functional connectivity. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 86). Retrieved from https://www.queenstownresearchweek.org Conference Contribution - Published proceedings: Abstract
Cawood, S., Neehoff, S., Glue, P., Williams, J., Ryan, M., Russell, B., & Harrison, O. (2022). Investigating the relationship between microRNA expression, brain structure and biochemistry in anxiety disorders and their potential treatment with ketamine. In K. Horne (Ed.), Proceedings of the 38th International Australasian Winter Conference on Brain Research (AWCBR). (pp. 82). Retrieved from https://www.queenstownresearchweek.org Conference Contribution - Published proceedings: Abstract
Wang, D., Jackson, C., Glue, P., Hung, N., Hung, T., & Duffull, S. (2022, August-September). Exploring go/no-go with oral docetaxel plus encequidar. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Shadli, S. M., Delany, R. G., Glue, P., & McNaughton, N. (2022). Right frontal theta: Is it a response biomarker for ketamine's therapeutic action in anxiety disorders? Frontiers in Neuroscience, 16, 900105. doi: 10.3389/fnins.2022.900105 Journal - Research Article
Abuhelwa, A. Y., Somogyi, A. A., Loo, C. K., Glue, P., Barratt, D. T., & Foster, D. J. R. (2022). Population pharmacokinetics and pharmacodynamics of the therapeutic and adverse effects of ketamine in patients with treatment-refractory depression. Clinical Pharmacology & Therapeutics, 112(3), 720-729. doi: 10.1002/cpt.2640 Journal - Research Article
Bayes, A., Short, B., Zarate, C. A., Park, L., Murrough, J. W., McLoughlin, D. M., … Glue, P., … Loo, C. K. (2022). The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry. Journal of Affective Disorders, 308, 44-46. doi: 10.1016/j.jad.2022.04.020 Journal - Research Article
Perez, T. M., Mathew, J., Glue, P., Adhia, D. B., & De Ridder, D. (2022). Is there evidence for the specificity of closed-loop brain training in the treatment of internalizing disorders? A systematic review. Frontiers in Neuroscience, 16, 821136. doi: 10.3389/fnins.2022.821136 Journal - Research Other
Goeldner, C., Kishnani, P. S., Skotko, B. G., Casero, J. L., Hipp, J. F., Derks, M., … and Clematis Study Group, including Glue, P. (2022). A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome. Journal of Neurodevelopmental Disorders, 14, 10. doi: 10.1186/s11689-022-09418-0 Journal - Research Article
Brown, A., & Glue, P. (2022). Possible mechanisms for treatment heterogeneity in clinical trials of adjunctive N-acetylcysteine for bipolar depression. Bipolar Disorders, 24(2), 213. doi: 10.1111/bdi.13152 Journal - Research Other
Whittaker, E., Dadabayev, A. R., Joshi, S. A., & Glue, P. (2021). Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders. Therapeutic Advances in Psychopharmacology, 11. doi: 10.1177/20451253211056743 Journal - Research Article
Lenagh-Glue, J., Potiki, J., Casey, H., Dawson, J., O'Brien, T., & Glue, P. (2021, September). Mental Health Advance Directive Statements (MAPS): Past, present and future. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Scientific Conference, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Shadli, S. M., Ando, L. C., McIntosh, J., Lodhia, V., Russell, B. R., Kirk, I. J., Glue, P., & McNaughton, N. (2021). Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports, 11, 19746. doi: 10.1038/s41598-021-99374-x Journal - Research Article
Stevenson, M. P., McEwan, J., Bentsen, P., Schilhab, T., Glue, P., Trani, P., Wheeler, B., & Healey, D. (2021). Nature walks versus medication: A pre-registered randomized-controlled trial in children with Attention Deficit/Hyperactivity Disorder. Journal of Environmental Psychology, 77, 101679. doi: 10.1016/j.jenvp.2021.101679 Journal - Research Article
Peng, M., Potterton, H., Chu, J. T. W., & Glue, P. (2021). Olfactory shifts linked to postpartum depression. Scientific Reports, 11(1), 14947. doi: 10.1038/s41598-021-94556-z Journal - Research Article
Perez, T., Glue, P., De Ridder, D., Adhia, D., & Mathew, J. (2021). Is there evidence for EEG-neurofeedback specificity in the treatment of internalizing disorders: A systematic review and meta-analysis. Proceedings of the International Society for Neuroregulation & Research (ISNR) 29th Annual Conference. Retrieved from https://isnr.org/ Conference Contribution - Published proceedings: Abstract
Krijgsman, A., Gallagher, S., Neehoff, S., & Glue, P. W. (2021). Pilot study of ketamine in phobic participants using virtual reality stimuli. New Zealand Medical Journal, 134(1537), (pp. 116). Retrieved from https://www.nzma.org.nz/journal Conference Contribution - Published proceedings: Abstract
Perez, T. M., Glue, P., Adhia, D. B., Mathew, J., & De Ridder, D. (2021). Is there evidence for EEG-neurofeedback specificity in the treatment of internalizing disorders? A protocol for a systematic review and meta-analysis. NeuroRegulation, 8(1), 22-28. doi: 10.15540/nr.8.1.22 Journal - Research Other
Glue, P., Russell, B., & Medlicott, N. J. (2021). Influence of formulation and route of administration on ketamine's safety and tolerability: Systematic review. European Journal of Clinical Pharmacology, 77, 671-676. doi: 10.1007/s00228-020-03047-z Journal - Research Other
Barak, Y., Barson, D., Davie, G., Glue, P., & Paleacu, D. (2021). Internalize at your peril: Internalizing disorders as risk factors for dementia: Cohort study. GeroScience, 43, 253-261. doi: 10.1007/s11357-020-00285-y Journal - Research Article
Lenagh-Glue, J., Potiki, J., O'Brien, A., Dawson, J., Thom, K., Casey, H., & Glue, P. (2021). Help and hindrances to completion of psychiatric advance directives. Psychiatric Services, 72(2), 216-218. doi: 10.1176/appi.ps.202000080 Journal - Research Other
Truppman Lattie, D., Nehoff, H., Neehoff, S., Gray, A., & Glue, P. (2021). Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale. Journal of Psychopharmacology, 35(2), 137-141. doi: 10.1177/0269881120953991 Journal - Research Article
Barak, Y., Leitch, S., & Glue, P. (2021). The Great Escape: Centenarians' exceptional health. Aging Clinical & Experimental Research, 33(3), 513-520. doi: 10.1007/s40520-020-01552-w Journal - Research Article
Neumann, S. R., Glue, P., & Linscott, R. J. (2021). Aberrant salience and reward processing: A comparison of measures in schizophrenia and anxiety. Psychological Medicine, 51, 1507-1515. doi: 10.1017/s0033291720000264 Journal - Research Article
Schep, L. J., Slaughter, R. J., Glue, P., & Gee, P. (2020). The clinical toxicology of cannabis. New Zealand Medical Journal, 133(1523), 96-103. Retrieved from https://www.nzma.org.nz/journal Journal - Research Other
Barak, Y., Neehoff, S., & Glue, P. (2020). Ageing badly: Indicators of old-age structure in Australia and New Zealand. Journal of Primary Health Care, 12(3), 272-276. doi: 10.1071/hc19095 Journal - Research Article
Glue, P., Medlicott, N. J., Neehoff, S., Surman, P., Lam, F., Hung, N., & Hung, C.-T. (2020). Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: Open label pilot study. Therapeutic Advances in Psychopharmacology, 10, 1-6. doi: 10.1177/2045125320922474 Journal - Research Article
Manigsaca, A., Glue, P., & O'Brien, A. (2020). Advance directives: Another gap in services for people with borderline personality disorder. Psychiatric Services, 71(5), 528-529. doi: 10.1176/appi.ps.71402 Journal - Research Other
Leong, S. L., Glue, P., Manning, P., Vanneste, S., Lim, L. J., Mohan, A., & De Ridder, D. (2020). Anterior cingulate cortex implants for alcohol addiction: A feasibility study. Neurotherapeutics, 17, 1287-1299. doi: 10.1007/s13311-020-00851-4 Journal - Research Article
Barak, Y., & Glue, P. (2020). Progesterone loading as a strategy for treating postpartum depression [Short communication]. Human Psychopharmacology, 35, e2731. doi: 10.1002/hup.2731 Journal - Research Other
McNaughton, N., & Glue, P. (2020). Ketamine and neuroticism: A double-hit hypothesis of internalizing disorders [Short communication]. Personality Neuroscience, 3, e2. doi: 10.1017/pen.2020.2 Journal - Research Other
Barak, Y., Cheung, G., Fortune, S., & Glue, P. (2020). No country for older men: Ageing male suicide in New Zealand. Australasian Psychiatry, 28(4), 383-385. doi: 10.1177/1039856220905304 Journal - Research Article
Glue, P., Medlicott, N. J., Surman, P., Lam, F., Hung, N., & Hung, C. T. (2020). Ascending-dose study of controlled-release ketamine tablets in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability. Journal of Clinical Pharmacology, 60(6), 751-757. doi: 10.1002/jcph.1573 Journal - Research Article
Short, B., Dong, V., Gálvez, V., Vulovic, V., Martin, D., Bayes, A. J., … Glue, P., … Loo, C. K. (2020). Development of the Ketamine Side Effect Tool (KSET). Journal of Affective Disorders, 266, 615-620. doi: 10.1016/j.jad.2020.01.120 Journal - Research Article
Lenagh-Glue, J., Thom, K., O'Brien, A., Potiki, J., Casey, H., Dawson, J., & Glue, P. (2020). The content of Mental Health Advance Preference statements (MAPs): An assessment of completed advance directives in one New Zealand health board. International Journal of Law & Psychiatry, 68, 101537. doi: 10.1016/j.ijlp.2019.101537 Journal - Research Article
Barak, Y., Leitch, S., Greco, P., & Glue, P. (2020). Fatigue, sleep and depression: An exploratory interRAI study of older adults [Short communication]. Psychiatry Research, 284, 112772. doi: 10.1016/j.psychres.2020.112772 Journal - Research Other
Glue, P., Neehoff, S., Sabadel, A., Broughton, L., Le Nedelec, M., Shadli, S., McNaughton, N., & Medlicott, N. J. (2020). Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study. Journal of Psychopharmacology, 34(3), 267-272. doi: 10.1177/0269881119874457 Journal - Research Article
Shadli, S. M., High, O., Byers, B., Gibbs, P., Steller, R., Glue, P., & McNaughton, N. (2020). Human anxiety-specific "theta" occurs with selective stopping and localizes to right inferior frontal gyrus. Behavioral Neuroscience, 134(6), 547-555. doi: 10.1037/bne0000316 Journal - Research Article
Glue, P. (2019, October). Ketamine for treatment-resistant depression and anxiety. Verbal presentation at the Otago Spotlight Series: Mental Health Research, Wellington, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Shadli, S. M., Glue, P., McNaughton, N., & Medlicott, N. (2019). Therapeutic effects of ketamine on treatment refractory generalized anxiety and social anxiety disorders are unrelated to plasma levels: A double blind active controlled study. Proceedings of the Society for Neuroscience Annual Meeting. 595.07/V21. SfN. Retrieved from https://www.sfn.org Conference Contribution - Published proceedings: Abstract
Allwood, C., O'Brien, A., & Glue, P. (2019). Referrals from primary care to community mental health teams: What's missing? Journal of Primary Health Care, 11(4), 334-341. doi: 10.1071/HC19053 Journal - Research Article
Glue, P. W., Medlicott, N. J., & Surman, P. W. (2019). Extended release pharmaceutical formulation. (10,441,544). United States. Intellectual Property
Mercier, K., Codyre, D., Galea-Singer, S., Christie, G., Glue, P., & Nightingale, S. (2019, September). High time for change: A debate on cannabis law reform [Debate]. Plenary presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) 2019 New Zealand Conference, Nelson, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P., & Barak, Y. (2019). Progesterone loading as a strategy for treating post-partum depression. Proceedings of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference. Retrieved from https://www.ranzcp2019.co.nz Conference Contribution - Published proceedings: Abstract
Barak, Y., Leitch, S., Gale, C., & Glue, P. (2019). No seasonal influence on cognitive performance in a national sample of older adults in New Zealand [Brief report]. Australasian Journal on Ageing, 29, e201-e204. doi: 10.1111/ajag.12733 Journal - Research Other
Abuhelwa, A. Y., Somogyi, A., Loo, C. K., Glue, P., & Foster, D. J. R. (2019). Population pharmacokinetic and pharmacodynamic modelling of the therapeutic and adverse effects of ketamine in patients with treatment-refractory depression. Proceedings of the Twenty-Eighth Annual Meeting of the Population Approach Group in Europe (PAGE). (pp. 22-23). Retrieved from https://www.page-meeting.org Conference Contribution - Published proceedings: Abstract
Thom, K., Lenagh-Glue, J., O'Brien, A. J., Potiki, J., Casey, H., Dawson, J., & Glue, P. (2019). Service user, whānau and peer support workers' perceptions of advance directives for mental health. International Journal of Mental Health Nursing, 28, 1296-1305. doi: 10.1111/inm.12637 Journal - Research Article
Johari, N., Glue, P., & Barak, Y. (2019). Screaming behaviour in response to electroconvulsive treatment: Psychogeriatric note on a patient with Alzheimer's disease. Psychogeriatrics, 19, 626-627. doi: 10.1111/psyg.12443 Journal - Research Other
Ortiz, V. G., Glue, P., Somogyi, A. A., Martin, D., Alonzo, A., Rodgers, A., … Loo, C. K. (2019). A reply to comments by Lee and colleagues on: Repeated intranasal ketamine for treatment resistant depression - the way to go? Results from a pilot randomised controlled trial. Journal of Psychopharmacology, 33(2), 260-261. doi: 10.1177/0269881118822147 Journal - Research Other
Gale, C., Glue, P., Guaiana, G., Coverdale, J., McMurdo, M., & Wilkinson, S. (2019). Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorders: Systematic review and meta-analysis. Journal of Psychopharmacology, 33(5), 543-547. doi: 10.1177/0269881118822146 Journal - Research Article
Gale, C., Glue, P., & Barak, Y. (2019). Low-risk and high-risk groups matter in suicide risk. Psychological Medicine, 49(5), 879-880. doi: 10.1017/S0033291718003422 Journal - Research Other
Neehoff, S., & Glue, P. (2019). Dissociation after ketamine dosing: Is the CADSS fit for purpose? Journal of Affective Disorders, 244, 239-240. doi: 10.1016/j.jad.2017.11.088 Journal - Research Other
Leitch, S., Glue, P., Gray, A., Greco, P., & Barak, Y. (2018, November). Dynamics of loneliness in the elderly: Unlonely female centenarians. Verbal presentation at the Women’s Wellbeing Symposium, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Bagshaw, S., Mulder, R., Porter, R., & Glue, P. (2018, July). Taking the pulse of mental health in New Zealand. Panel discussion at the University of Otago Winter Symposium Series, Christchurch, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Admiraal, A., Gale, C., Pollock, L., Bathgate, D., Glue, P., & Barak, Y. (2018). Refining medical students' risk assessment skills: Lifecycle scenarios. Proceedings of the Higher Education Development Centre (HEDC) Symposium: Celebrating Higher Education. (pp. 18). Retrieved from https://www.otago.ac.nz/hedc Conference Contribution - Published proceedings: Abstract
Barak, Y., & Glue, P. (2018). Do social isolation and loneliness kill People with Alzheimer's disease? OBM Geriatrics, (2), 4. doi: 10.21926/obm.geriatr.1804021 Journal - Professional & Other Non-Research Articles
Lenagh-Glue, J., O'Brien, A., Dawson, J., Thom, K., Potiki, J., Casey, H., & Glue, P. (2018). A MAP to mental health: The process of creating a collaborative advance preferences instrument. New Zealand Medical Journal, 131(1486), 18-26. Retrieved from https://www.nzma.org.nz/journal Journal - Research Article
Leitch, S., Glue, P., Gray, A. R., Greco, P., & Barak, Y. (2018). Comparison of psychosocial variables associated with loneliness in centenarian vs elderly populations in New Zealand. JAMA Network Open, 1(6), e183880. doi: 10.1001/jamanetworkopen.2018.3880 Journal - Research Article
Byers, B., Shadli, S. M., High, O., Gibbs, P., Steller, R., Glue, P., & McNaughton, N. (2018). Generalisation of an anxiety process biomarker from speeded response to bimanual fixed time responding. In K. Hillman (Ed.), Proceedings of the 36th International Australasian Winter Conference on Brain Research. (pp. 44). AWCBR. Retrieved from https://www.otago.ac.nz/awcbr Conference Contribution - Published proceedings: Abstract
Shadli, S. M., Kawe, T., Martin, D., McNaughton, N., Neehoff, S., & Glue, P. (2018). Ketamine effects on EEG during therapy of treatment-resistant generalized anxiety and social anxiety. In K. Hillman (Ed.), Proceedings of the 36th International Australasian Winter Conference on Brain Research. (pp. 31). AWCBR. Retrieved from https://www.otago.ac.nz/awcbr Conference Contribution - Published proceedings: Abstract
Glue, P. (2018, August). Ketamine, anxiety, depression and personality traits. Department of Medicine, University of Otago, Dunedin, New Zealand. [Department Seminar]. Other Research Output
Le Nedelec, M., Glue, P., Winter, H., Goulton, C., & Medlicott, N. J. (2018). The effect of route of administration on the enantioselective pharmacokinetics of ketamine and norketamine in rats. Journal of Psychopharmacology, 32(10), 1127-1132. doi: 10.1177/0269881118780013 Journal - Research Article
Menkes, D., Grundy, Q., Every-Palmer, S., Bates, A., Parry, P., Battersby, M., Monasterio, E., Rae, A., … Glue, P., & Newton-Howes, G. (2018). Benefits, harms and ethical implications of sponsored education in psychiatry. Australian & New Zealand Journal of Psychiatry, 52(Suppl. 1), (pp. 52-53). doi: 10.1177/0004867418764980 Conference Contribution - Published proceedings: Abstract
Glue, P. (2018). Neurological adverse effects of antipsychotics: Forcus on NMS and seizures. Australian & New Zealand Journal of Psychiatry, 52(Suppl. 1), (pp. 46). doi: 10.1177/0004867418764980 Conference Contribution - Published proceedings: Abstract
Glue, P. (2018). Setting up a ketamine clinic for patients with refractory major depression. Australian & New Zealand Journal of Psychiatry, 52(Suppl. 1), (pp. 14-15). doi: 10.1177/0004867418764980 Conference Contribution - Published proceedings: Abstract
Every-Palmer, S., Flanagan, R., Glue, P., Menkes, D. B., & Kenedi, C. (2018). Best evidence to best practice: Preventing and managing the life-threatening adverse effects of antipsychotic medication. Australian & New Zealand Journal of Psychiatry, 52(Suppl. 1), (pp. 45). doi: 10.1177/0004867418764980 Conference Contribution - Published proceedings: Abstract
Glue, P. & McNaughton, N. (2018, May). Using drugs to redefine psychiatric disorders: Ketamine and neuroticism. Bioethics Centre, University of Otago, Dunedin, New Zealand. [Department Seminar]. Other Research Output
Glue, P., & Barak, Y. (2018). Prazosin for post-traumatic stress disorder. New England Journal of Medicine, 378(17), 1648-1650. doi: 10.1056/NEJMc1803171 Journal - Research Other
Shadli, S. M., Kawe, T., Martin, D., McNaughton, N., Neehoff, S., & Glue, P. (2018). Ketamine effects on EEG during therapy of treatment-resistant generalized anxiety and social anxiety. International Journal of Neuropsychopharmacology, 21(8), 717-724. doi: 10.1093/ijnp/pyy032 Journal - Research Article
Glue, P., Neehoff, S. M., Medlicott, N. J., Gray, A., Kibby, G., & McNaughton, N. (2018). Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders. Journal of Psychopharmacology, 32(6), 663-667. doi: 10.1177/0269881118762073 Journal - Research Article
Gálvez, V., Li, A., Huggins, C., Glue, P., Martin, D., Somogyi, A. A., … Loo, C. K. (2018). Repeated intranasal ketamine for treatment-resistant depression: The way to go? Results from a pilot randomised controlled trial. Journal of Psychopharmacology, 32(4), 397-407. doi: 10.1177/0269881118760660 Journal - Research Article
Gale, C., & Glue, P. (2018). How comprehensive is suicide risk assessment in the emergency department? New Zealand Medical Journal, 131(1470), 11-13. Retrieved from https://www.nzma.org.nz/journal Journal - Research Other
Le Nedelec, M., Glue, P., Winter, H., Goulton, C., Broughton, L., & Medlicott, N. (2018). Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations. Drug Delivery & Translational Research, 8(3), 780-786. doi: 10.1007/s13346-017-0476-2 Journal - Research Article
Menkes, D. B., Glue, P., Gale, C., Lam, F., Hung, C.-T., & Hung, N. (2018). Steady-state clozapine and norclozapine pharmacokinetics in Māori and European patients. EBioMedicine, 27, 134-137. doi: 10.1016/j.ebiom.2017.11.030 Journal - Research Article
Gale, C., Glue, P., & Gray, A. (2017). A Bayesian re-analysis of suicide screening: A systematic review. Proceedings of the 17th World Congress of Psychiatry. WPA. Retrieved from http://www.wpanet.org Conference Contribution - Published proceedings: Abstract
Shadli, S. M., High, O., Gibbs, P., Glue, P., & McNaughton, N. (2017). Generalization of goal conflict specific rhythmicity to a bimanual anticipatory response inhibition task shows sensitivity to anxiolytics. In B. Leitch (Ed.), Proceedings of the 35th International Australasian Winter Conference on Brain Research. (pp. 45). AWCBR. Retrieved from http://www.otago.ac.nz/awcbr/index.html Conference Contribution - Published proceedings: Abstract
Glue, P. (2017, September). Effects of ketamine on anxiety symptoms in patients with treatment-refractory anxiety disorders. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Kia Kotahi ai ngā Ara: Uniting the Pathways, Tauranga, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2017, September). Preclinical and clinical studies of cannabinoid treatment. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Kia Kotahi ai ngā Ara: Uniting the Pathways, Tauranga, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Castle, C., Gray, A., Neehoff, S., & Glue, P. (2017). Effect of ketamine dose on self-rated dissociation in patients with treament refractory anxiety disorders. Journal of Psychopharmacology, 31(10), 1306-1311. doi: 10.1177/0269881117725685 Journal - Research Article
George, D., Gálvez, V., Martin, D., Kumar, D., Leyden, J., Hadzi-Pavlovic, D., … Glue, P., … Loo, C. K. (2017). Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression. American Journal of Geriatric Psychiatry, 25(11), 1199-1209. doi: 10.1016/j.jagp.2017.06.007 Journal - Research Article
Glue, P., Medlicott, N. J., Harland, S., Neehoff, S., Anderson-Fahey, B., Le Nedelec, M., Gray, A., & McNaughton, N. (2017). Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. Journal of Psychopharmacology, 31(10), 1302-1305. doi: 10.1177/0269881117705089 Journal - Research Article
Glue, P., & Menkes, D. B. (2017). Ketamine and suicidal ideation: Direct effect or epiphenomenon? Journal of Clinical Psychopharmacology, 37(2), 1. doi: 10.1097/jcp.0000000000000646 Journal - Research Other
De Ridder, D., Leong, S. L., Manning, P., Vanneste, S., & Glue, P. (2017). Anterior cingulate implant for obsessive-compulsive disorder. World Neurosurgery, 97, 754.e7-754.e16. doi: 10.1016/j.wneu.2016.10.046 Journal - Research Other
Malhi, G., Glue, P., Roy, H., Menkes, D., Jureidini, J., & Toop, L. (2016, October). This house believes that the pharmaceutical industry does more good than harm in the ongoing development and promotion of treatments in psychiatry [Debate]. Invited presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference: Recover, Rebuild, Regenerate, Christchurch, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2016, October). The highs and lows of synthetic cannabinoids. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference: Recover, Rebuild, Regenerate, Christchurch, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Courts, J., Maskill, V., Gray, A., & Glue, P. (2016). Signs and symptoms associated with synthetic cannabinoid toxicity: Systematic review. Australasian Psychiatry, 24(6), 598-601. doi: 10.1177/1039856216663733 Journal - Research Article
Whigham, P. A., de Graaf, B., Srivastava, R., & Glue, P. (2016). Managing distance and covariate information with point-based clustering. BMC Medical Research Methodology, 16(1), 115. doi: 10.1186/s12874-016-0218-z Journal - Research Article
French, J., Glue, P., Friedman, D., Almas, M., Yardi, N., Knapp, L., … Posner, H. B. (2016). Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes. Neurology, 87(12), 1242-1249. doi: 10.1212/wnl.0000000000003118 Journal - Research Article
Xu, Y., Hackett, M., Carter, G., Loo, C., Gálvez, V., Glozier, N., Glue, P., … Rodgers, A. (2016). Effects of low-dose and very low-dose ketamine among patients with major depression: A systematic review and meta-analysis. International Journal of Neuropsychopharmacology, 19(4), 1-15. doi: 10.1093/ijnp/pyv124 Journal - Research Article
Forsyth, B., Machado, L., Jowett, T., Jakobi, H., Garbe, K., Winter, H., & Glue, P. (2016). Effects of low dose ibogaine on subjective mood state and psychological performance. Journal of Ethnopharmacology, 189, 10-13. doi: 10.1016/j.jep.2016.05.022 Journal - Research Article
Glue, P., Courts, J., Gray, A., & Patterson, T. (2016). Influence of law changes affecting synthetic cannabinoid availability and frequency of hospital presentations: 4-year national survey. New Zealand Medical Journal, 129(1433), 41-44. Retrieved from http://www.nzma.org.nz/journal Journal - Research Article
De Ridder, D., Manning, P., Glue, P., Cape, G., Langguth, B., & Vanneste, S. (2016). Anterior cingulate implant for alcohol dependence. Neurosurgery, 78(6), E883-E893. doi: 10.1227/neu.0000000000001248 Journal - Research Other
Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Hung, N., … Harland, S., … Friedhoff, L. (2016). Ascending single-dose, double-blind, placebo-controlled safety study of noribogaine in opioid-dependent patients. Clinical Pharmacology in Drug Development, 5(6), 460-468. doi: 10.1002/cpdd.254 Journal - Research Article
Loo, C. K., Gálvez, V., O'Keefe, E., Mitchell, P. B., Hadzi-Pavlovic, D., Leyden, J., … Glue, P. (2016). Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatrica Scandinavica, 134(1), 48-56. doi: 10.1111/acps.12572 Journal - Research Article
De Ridder, D., Manning, P., Cape, G., Vanneste, S., Langguth, B., & Glue, P. (2016). Pathophysiology-based neuromodulation for addictions: An overview. In V. R. Preedy (Ed.), Neuropathology of drug addictions and substance misuse (Vol. 1: Foundations of understanding, tobacco, alcohol, cannabinoids and opioids). (pp. 14-24). London: Elsevier. doi: 10.1016/B978-0-12-800213-1.00002-X Chapter in Book - Research
Shadli, S. M., Smith, M. J., Glue, P., & McNaughton, N. (2016). Testing an anxiety process biomarker: Generalisation from an auditory to a visual stimulus. Biological Psychology, 117, 50-55. doi: 10.1016/j.biopsycho.2016.02.011 Journal - Research Article
De Ridder, D., Vanneste, S., Gillett, G., Manning, P., Glue, P., & Langguth, B. (2016). Psychosurgery reduces uncertainty and increases free will? A review. Neuromodulation, 19, 239-248. doi: 10.1111/ner.12405 Journal - Research Article
Glue, P., Cape, G., Tunnicliff, D., Lockhart, M., Lam, F., Gray, A., Hung, N., … Harland, S., … Friedhoff, L. (2016). Switching opioid-dependent patients from methadone to morphine: Safety, tolerability, and methadone pharmacokinetics. Journal of Clinical Pharmacology, 56(8), 960-965. doi: 10.1002/jcph.704 Journal - Research Article
Shadli, S. M., Glue, P., McIntosh, J., & McNaughton, N. (2015). An improved human anxiety process biomarker: Characterization of frequency band, personality and pharmacology. Translational Psychiatry, 5, e699. doi: 10.1038/tp.2015.188 Journal - Research Article
Glue, P., & Herbison, P. (2015). Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis. Australian & New Zealand Journal of Psychiatry, 49(12), 1215-1220. doi: 10.1177/0004867415614109 Journal - Research Article
Mellsop, G., Ellis, P. M., Glue, P., Gale, C., Mulder, R., & Menkes, D. B. (2015). Risk management and clinical practice. New Zealand Medical Journal, 128(1424). Retrieved from https://www.nzma.org.nz/journal Journal - Research Other
Gale, C., & Glue, P. (2015, September). Screening the general population for suicide: An application of Bayes' theorem. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference, Hamilton, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2015, September). Ketamine update in affective disorders. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference, Hamilton, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2015, September). Ibogaine and opioid withdrawal: Does it work and is it safe? Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists New Zealand Conference, Hamilton, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Shadli, S., Glue, P., Kirk, I., & McNaughton, N. (2015). An improved human anxiety-specific biomarker: Personality, pharmacology, frequency band, and source characterisation. Frontiers in Human Neuroscience, doi: 10.3389/conf.fnhum.2015.217.00315 Conference Contribution - Published proceedings: Abstract
Gale, C., Menkes, D., & Glue, P. (2015). Assessment needs to be part of humane care. BMJ, 351, h4315. doi: 10.1136/bmj.h4315 Journal - Professional & Other Non-Research Articles
Hendry, K., Glue, P., Hill, J., & Schultz, M. (2015). Ingestion of sharp foreign objects: A case series, literature review and management recommendation [Case review]. Journal of Gastric Disorders & Therapy, 1(1). doi: 10.16966/jgdt.101 Journal - Research Other
Glue, P., Courts, J., Gale, C., & Mason, E. (2015). Implementation of the 2013 Psychoactive Substances Act and mental health harms from synthetic cannabinoids. New Zealand Medical Journal, 128(1414). Retrieved from https://www.nzma.org.nz/journal Journal - Research Article
Glue, P., Winter, H., Garbe, K., Jakobi, H., Lyudin, A., Lenagh-Glue, Z., & Hung, C. T. (2015). Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers. Journal of Clinical Pharmacology, 55(6), 680-687. doi: 10.1002/jcph.471 Journal - Research Article
Henderson, S., Porter, R. J., Basset, D., Battersby, M., Baune, B. T., Byrne, G. J., Ellis, P. M., … Glue, P., … Luty, S. E., … Mulder, R., … Malhi, G. S. (2015). Why academic psychiatry is endangered. Australian & New Zealand Journal of Psychiatry, 49(1), 9-12. doi: 10.1177/0004867414563453 Journal - Research Other
Glue, P., Lockhart, M., Lam, F., Hung, N., Hung, C.-T., & Friedhoff, L. (2015). Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability. Journal of Clinical Pharmacology, 55(2), 189-194. doi: 10.1002/jcph.404 Journal - Research Article
Dawson, J., Glue, P., Ellis, P. M., Lenagh-Glue, J., Goldsmith, D., & Smith, D. A. R. (2015). Lessons from export to New Zealand of the second opinion appointed doctor scheme. BJPsych Bulletin, 39(2), 69-73. doi: 10.1192/pb.bp.113.046540 Journal - Research Article
Shadli, S. M., Glue, P., & McNaughton, N. (2014). Anxiolytic drug action in the stop signal task: α-asymmetry is not like goal conflict-specific rhythmicity. Proceedings of the Society for Neuroscience 44th Annual Meeting. SfN. Retrieved from http://www.sfn.org/annual-meeting/neuroscience-2014/abstracts Conference Contribution - Published proceedings: Abstract
Glue, P., Gale, C., & Parnell, W. (2014). Impact of dietary benzoic acid on treatment response in schizophrenia. JAMA Psychiatry, 71(11), 1298-1299. doi: 10.1001/jamapsychiatry.2014.673 Journal - Research Other
Wilkinson, S., Gale, C., & Glue, P. (2014, October). What influences the effectiveness of benzodiazepines in generalized anxiety disorder? Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Deep South Psychiatry, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P., Alvarez-Grandi, S., & Seifert, A. (2014, October). ECT use patterns in Otago: 10 year retrospective audit. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Deep South Psychiatry, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Johnson, R., Gillett, G., & Glue, P. (2014, October). Deep brain stimulation for schizophrenia: Time for a clinical trial? Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Deep South Psychiatry, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2014, October). Update on ketamine in depression. Invited presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Deep South Psychiatry, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Shadli, S. M., Glue, P., Kirk, I. J., & McNaughton, N. (2014). An improved human anxiety-specific biomarker: Personality, pharmacology, frequency band, and source characterisation. In B. Leitch & J. Shemmell (Eds.), Proceedings of the 32nd International Australasian Winter Conference on Brain Research. 32, (pp. 33). AWCBR. Retrieved from https://web.psy.otago.ac.nz/awcbr/proceedings.html Conference Contribution - Published proceedings: Abstract
Shelker, W., Zaharic, T., Sijnja, B., & Glue, P. (2014). Influence of rural background and rural medical training on postgraduate medical training and location in New Zealand. New Zealand Medical Journal, 127(1403). Retrieved from http://www.nzma.org.nz/journal Journal - Research Article
Baby, M., Glue, P., & Carlyle, D. (2014). 'Violence is not part of our job': A thematic analysis of psychiatric mental health nurses' experiences of patient assaults from a New Zealand perspective. Issues in Mental Health Nursing, 35(9), 647-655. doi: 10.3109/01612840.2014.892552 Journal - Research Article
Lai, R., Katalinic, N., Glue, P., Somogyi, A. A., Mitchell, P. B., Leyden, J., … Loo, C. K. (2014). Pilot dose–response trial of i.v. ketamine in treatment-resistant depression. World Journal of Psychiatry, 15(7), 579-584. doi: 10.3109/15622975.2014.922697 Journal - Research Article
Campbell, A., Ruffman, T., Murray, J. E., & Glue, P. (2014). Oxytocin improves emotion recognition for older males. Neurobiology of Aging, 35(10), 2246-2248. doi: 10.1016/j.neurobiolaging.2014.04.021 Journal - Research Article
Dyke, J., Hendry, K., Hill, J., Schultz, M., Mason, E., & Glue, P. (2014). Management of a cluster of foreign body ingestion incidents in patients with borderline personality disorder. Open Journal of Psychiatry, 4, 99-103. doi: 10.4236/ojpsych.2014.42014 Journal - Research Article
Gupta, S. K., Kantesaria, B., & Glue, P. (2014). Exploring the influence of renal dysfunction on the pharmaco-kinetics of ribavirin after oral and intravenous dosing. Drug Discoveries & Therapeutics, 8(2), 89-95. doi: 10.5582/ddt.8.89 Journal - Research Article
Lenagh-Glue, J., Glue, P., & Dawson, J. (2014). When the mandatory second opinion fails to approve compulsory treatment. Australasian Psychiatry, 22(4), 337-340. doi: 10.1177/1039856214537879 Journal - Research Article
Shelker, W., Poole, P., Bagg, W., Wood, I., & Glue, P. (2014). Postgraduation retention of medical students from Otago and Auckland medical programmes. New Zealand Medical Journal, 127(1388). Retrieved from http://www.nzma.org.nz/journal Journal - Research Article
Gálvez, V., O'Keefe, E., Cotiga, L., Leyden, J., Harper, S., Glue, P., … Loo, C. K. (2014). Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: A Case Report. Biological Psychiatry, 76, e1-e2. doi: 10.1016/j.biopsych.2013.12.010 Journal - Research Other
Alvarez-Grandi, S., Leon de la Barra, S., Seifert, A., & Glue, P. (2014). Electroconvulsive therapy use in Otago, New Zealand: A 10-year retrospective audit of patient-level treatment data. Australian & New Zealand Journal of Psychiatry, 48(6), 548-553. doi: 10.1177/0004867413514119 Journal - Research Article
Gale, C., Glue, P., Gallagher, S., & Gray, A. (2013, October). Bayesean analysis as a predictor of outcome rate. Verbal presentation at the World Psychiatric Association International Congress, Vienna, Austria. Conference Contribution - Verbal presentation and other Conference outputs
Gale, C., Payne-Harker, M., Wilkinson, S., Guaiana, G., Glue, P., Coverdale, J., & Herbison, P. (2013, December). Are benzodiazepines safe and efficacious in generalized anxiety disorder? A meta-analysis against placebo. Poster session presented at the Australasian Society for Psychiatric Research (ASPR) Conference, Melbourne, Australia. Conference Contribution - Poster Presentation (not in published proceedings)
Campbell, A., Ruffman, T., Murray, J., & Glue, P. (2013). Oxytocin improves emotion recognition for older males. Gerontologist, 53(Suppl. 1), (pp. 464). doi: 10.1093/geront/gnt151 Conference Contribution - Published proceedings: Abstract
Gale, C., Glue, P., & Gallagher, S. (2013, September). Bayesian analysis of post-test predictive value of screening instruments for the psychosis high risk state. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Conference: The Shifting Strands of Psychiatry, Auckland, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Menkes, D. B., Glue, P., Gale, C., & Hung, N. (2013, September). Steady-state clozapine pharmacokinetics in Maori and European patients. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Conference: The Shifting Strands of Psychiatry, Auckland, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P., Gale, C., Schep, L., Strong, B., Al-Shaqsi, S., & Hancock, D. (2013, September). Hospitalisation associated with use of the synthetic cannabinoid K2. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Conference: The Shifting Strands of Psychiatry, Auckland, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Dawson, J., Ellis, P., Glue, P., Goldsmith, D., Lenagh-Glue, J., & Smith, D. (2013, September). Mandatory second opinions on compulsory treatment. Verbal presentation at the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Conference: The Shifting Strands of Psychiatry, Auckland, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Gupta, S. K., Kantesaria, B., & Glue, P. (2013). Pharmacokinetics and safety of single-dose ribavirin in patients with chronic renal impairment. Drug Discoveries & Therapeutics, 7(4), 158-163. doi: 10.5582/ddt.2013.v7.4.158 Journal - Research Article
Glue, P. (2013, November). Drug repurposing. Verbal presentation at the New Zealand Anaesthesia (NZA) Annual Scientific Meeting, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Henry, M. E., Bolo, N. R., Zuo, C. S., Villafuerte, R. A., Cayetano, K., Glue, P., … Renshaw, P. F. (2013). Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy. Antimicrobial Agents & Chemotherapy, 57(11), 5271-5276. doi: 10.1128/AAC.00394-13 Journal - Research Article
Dawson, J., Ellis, P., Glue, P., Goldsmith, D., Lenagh-Glue, J., & Smith, D. A. R. (2013). Mandatory second opinions on compulsory treatment. In J. Dawson & K. Gledhill (Eds.), New Zealand's Mental Health Act in practice. (pp. 229-246). Wellington, New Zealand: Victoria University Press. Chapter in Book - Research
Gale, C., Glue, P., & Gallagher, S. (2013). Bayesian analysis of posttest predictive value of screening instruments for the psychosis high-risk state. JAMA Psychiatry, 70(8), 880-881. doi: 10.1001/jamapsychiatry.2013.1320 Journal - Research Other
Glue, P., Al-Shaqsi, S., Hancock, D., Gale, C., Strong, B., & Schep, L. (2013). Hospitalisation associated with use of the synthetic cannabinoid K2. New Zealand Medical Journal, 126(1377). Retrieved from http://www.nzma.org.nz/journal Journal - Research Article
Katalinic, N., Lai, R., Somogyi, A., Mitchell, P. B., Glue, P., & Loo, C. K. (2013). Ketamine as a new treatment for depression: A review of its efficacy and adverse effects. Australian & New Zealand Journal of Psychiatry, 47(8), 710-727. doi: 10.1177/0004867413486842 Journal - Research Article
Grott Zanicotti, C., Perez, D., & Glue, P. (2013). Long-term mood response to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. Journal of Palliative Medicine, 16(7), 719-720. doi: 10.1089/jpm.2013.0057 Journal - Research Other
Shelker, W., Herbison, P., Belton, A., & Glue, P. (2013). Factors related to postgraduate retention of medical graduates in New Zealand. New Zealand Medical Journal, 126(1371). Retrieved from http://www.nzma.org.nz/journal Journal - Research Article
Chai, Y. K., Wheeler, Z., Herbison, P., Gale, C., & Glue, P. (2013). Factors associated with hospitalization of adult psychiatric patients: Cluster analysis. Australasian Psychiatry, 21(2), 141-146. doi: 10.1177/1039856213475682 Journal - Research Article
Glue, P., & Gale, C. (2013). Do all antidepressants cause QT prolongation: How good is the evidence? New Zealand Medical Journal, 126(1369). Retrieved from http://www.nzma.org.nz/journal Journal - Research Other
McNaughton, N., Swart, C., Neo, P., Bates, V., & Glue, P. (2013). Anti-anxiety drugs reduce conflict-specific “theta”: A possible human anxiety-specific biomarker. Journal of Affective Disorders, 148(1), 104-111. doi: 10.1016/j.jad.2012.11.057 Journal - Research Article
Patterson, T., Rapsey, C. M., & Glue, P. (2013). Systematic review of cognitive development across childhood in Down syndrome: Implications for treatment interventions. Journal of Intellectual Disability Research, 57(4), 306-318. doi: 10.1111/j.1365-2788.2012.01536.x Journal - Research Article
Foster, C. A., Hiestand, P. C., & Glue, P. W. (2012). Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders. (2010246492). Australia. Intellectual Property
Menkes, D., Shaw, S., & Glue, P. (2012). Cultivating medical student interest in psychiatry. Australian & New Zealand Journal of Psychiatry, 46(Suppl. 1), (pp. 54). doi: 10.1177/0004867412445952 Conference Contribution - Published proceedings: Abstract
Gale, C., Herbison, G. P., Glue, P., Coverdale, J., & Guaiana, G. (2012). Benzodizepines for generalised anxiety disorder (GAD) (Protocol). Cochrane Database of Systematic Reviews, 11, CD001846. doi: 10.1002/14651858.CD001846.pub3 Journal - Research Other
Glue, P., Gale, C., Menkes, D. B., & Hung, N. (2012). Evaluation of bioequivalence between clozapine suspension and tablet formulations : A multiple-dose, fed and fasted Study. Clinical Drug Investigation, 32(11), 723-727. doi: 10.1007/s40261-012-0004-6 Journal - Research Article
Canton, J., Scott, K., & Glue, P. (2012). Optimal treatment of social phobia: Systematic review and meta-analysis. Neuropsychiatric Disease & Treatment, 8, 203-215. doi: 10.2147/ndt.s23317 Journal - Research Article
Glue, P., & Tarr, G. (2012). Comparative efficacy of anti-manic drugs in acute mania. Lancet, 379(9819), 892. doi: 10.1016/s0140-6736(12)60388-2 Journal - Research Other
Grott Zanicotti, C., Perez, D., & Glue, P. (2012). Mood and pain responses to repeat dose intramuscular ketamine in a depressed patient with advanced cancer. Journal of Palliative Medicine, 15(4), 400-403. doi: 10.1089/jpm.2011.0314 Journal - Research Article
Gupta, S. K., Kantesaria, B., & Glue, P. (2012). Pharmacokinetics, safety, and tolerability of ribavirin in hemodialysis-dependent patients. European Journal of Clinical Pharmacology, 68(4), 415-418. doi: 10.1007/s00228-011-1137-x Journal - Research Article
Grott-Zanicotti, C., Perez, D., & Glue, P. (2011, September). Acute and maintenance IM ketamine for depression in terminal cancer: Case report. Verbal presentation at the The Royal Australian and New Zealand College of Psychiatrists' New Zealand (RANZCP) Conference: Psychiatry in the field: Cultivating and diversifying our expertise? Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2011, November). The science of depression in IFN treated pts. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2011, November). Clinical research in NZ. Verbal presentation at the New Zealand Society of Gastroenterology & NZNO Gastroenterology Nurses Section Annual Scientific Meeting, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2011, July). Fast and slow treatments for affective disorders. Verbal presentation at the Brain Health Research Centre Conference, Dunedin, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2011, September). Factors associated with treatment response in acute mania drug trials. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Psychiatry in the field: Cultivating and diversifying our expertise? Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P. (2011, September). Fast and slow drug treatments for affective disorders. Verbal presentation at the Royal Australian & New Zealand College of Psychiatrists (RANZCP) New Zealand Conference: Psychiatry in the field: Cultivating and diversifying our expertise? Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Shelker, W., Belton, A., & Glue, P. (2011). Academic performance and career choices of older medical students at the University of Otago. New Zealand Medical Journal, 124(1346). Retrieved from http://journal.nzma.org.nz/journal/124-1346/4965/content.pdf Journal - Research Article
Rapsey, C., Patterson, T., & Glue, P. (2011). Cognitive development across childhood in Down syndrome: A systematic review. Proceedings of the 17th Biennial Conference of the Australasian Human Development Association (AHDA). (pp. 70). Retrieved from http://www.otago.ac.nz/ahda2011/ Conference Contribution - Published proceedings: Abstract
Malhotra, B., Darsey, E., Crownover, P., Fang, J., & Glue, P. (2011). Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers. British Journal of Clinical Pharmacology, 72(2), 226-234. doi: 10.1111/j.1365-2125.2011.03948.x Journal - Research Article
Glue, P., & Gale, C. (2011). [Response to the letter to the editor Off-label treatment]. New Zealand Medical Journal, 124(1338). Retrieved from http://journal.nzma.org.nz/journal/124-1338/4774/content.pdf Journal - Research Other
Glue, P., & Gale, C. (2011). Off-label use of quetiapine in New Zealand: A cause for concern? [Editorial]. New Zealand Medical Journal, 124(1336). Retrieved from http://journal.nzma.org.nz/journal/124-1336/4703/content.pdf Journal - Research Other
Gandelman, K., Zhu, T., Fahmi, O. A., Glue, P., Lian, K., Obach, S., & Damle, B. (2011). Unexpected effect of rifampin on the pharmacokinetics of linezolid: In silico and in vitro approaches to explain its mechanism. Journal of Clinical Pharmacology, 51(2), 229-236. doi: 10.1177/0091270010366445 Journal - Research Article
Gandelman, K., Glue, P., Laskey, R., Jones, J., LaBadie, R., & Ose, L. (2011). An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. Pediatric Cardiology, 32(4), 433-441. doi: 10.1007/s00246-011-9885-z Journal - Research Article
Malhotra, B., Darsey, E., Crownover, P., Fang, J., & Glue, P. (2011). Comparison of pharmcokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers. British Journal of Pharmacology, 72(2), 226-234. doi: 10.1111/j.1365-2125.2011.03948.x Journal - Research Article
Brier, M. E., Gaylor, S. K., McGovren, P., Glue, P., Fang, A., & Aronoff, G. R. (2011). Pharmacokinetics of dexrazoxane in subjects with impaired kidney function. Journal of Clinical Pharmacology, 51(5), 731-738. doi: 10.1177/0091270010369675 Journal - Research Article
Karayal, O. N., Glue, P., Bachinsky, M., Stewart, M., Chappell, P., Kolluri, S., & Cavus, I. (2011). Switching from quetiapine to ziprasidone: A sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder. Journal of Psychiatric Practice, 17(2), 100-109. doi: 10.1097/01.pra.0000396061.05269.c8 Journal - Research Article
Glue, P., Gulati, A., Le Nedelec, M., & Duffull, S. (2011). Dose- and exposure-response to ketamine in depression [Letter to the editor]. Biological Psychiatry, 70(4), e9-e10. doi: 10.1016/j.biopsych.2010.11.031 Journal - Research Other
Tarr, G. P., Herbison, G. P., Leon de la Barra, S., & Glue, P. (2011). Study design and patient characteristics and outcome in acute mania clinical trials. Bipolar Disorders, 13(2), 125-132. doi: 10.1111/j.1399-5618.2011.00904.x Journal - Research Article
Tarr, G. P., Glue, P., & Herbison, P. (2011). Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania: A systematic review and meta-analysis. Journal of Affective Disorders, 134(1-3), 14-19. doi: 10.1016/j.jad.2010.11.009 Journal - Research Article
Glue, P. W., McAllister, K. H., & Weber, E. (2010). Use of neurokinin antagonists in the treatment of urinary incontinence. (US 7,776,851). Intellectual Property
Glue, P., Loan, A., & Gale, C. (2010). New prospects for the drug treatment of generalized anxiety disorder: A systematic review. Current Drug Therapy, 5(2), 86-94. Journal - Research Article
Gandelman, K., Glue, P., Laskey, R., Jones, J., LaBadie, R., & Ose, L. (2010). An 8-week trial investigating the efficacy and tolerability of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia (HeFH). Atherosclerosis Supplements. 11(2), (pp. 122). [Abstract] Conference Contribution - Published proceedings: Abstract
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010). Meta-analysis of relapse prevention antidepressant trials in depressive disorders. Australian & New Zealand Journal of Psychiatry, 44(8), 697-705. doi: 10.3109/00048671003705441 Journal - Research Article
Gandelman, K., Glue, P., Malhotra, B., Gastonguay, M., Knebel, W., & Jen, J. (2010). Population pharmacokinetic (PopPK) and pharmacodynamic (PD) modeling of atorvastatin and its active metabolite in pediatric patients with heterozygous familial hypercholesterolemia (HeFH). Clinical Pharmacology and Therapeutics. 87(Suppl. 1), (pp. S61-S62). [Abstract] Conference Contribution - Published proceedings: Abstract
Donovan, M. R., Glue, P., Kolluri, S., & Emir, B. (2010). Comparative efficacy of antidepressants in preventing relapse in anxiety disorders: A meta-analysis. Journal of Affective Disorders, 123(1-3), 9-16. doi: 10.1016/j.jad.2009.06.021 Journal - Research Other
Alemayehu, D., Andrews, E. N., Glue, P., & Knirsch, C. A. (2010). Considerations for the design and conduct of a pharmacovigilance study involving mass drug administration in a resource-constrained setting. PLoS Neglected Tropical Diseases, 4(1), e564. doi: 10.1371/journal.pntd.0000564 Journal - Research Article
Sweeney, K. R., Gastonguay, M. R., Benincosa, L., Cronenberger, C. L., Glue, P., & Malhotra, B. K. (2010). Exposure-response modeling and clinical trial simulation of the effect of tolterodine on QT intervals in healthy volunteers. Drug Discoveries & Therapeutics, 4(1), 44-53. Journal - Research Article
Simpson, D. M., Schifitto, G., Clifford, D. B., Murphy, T. K., Durso-De Cruz, E., Glue, P., … On behalf of the 1066 HIV Neuropathy Study Group. (2010). Pregabalin for painful HIV neuropathy: A randomized, double-blind, placebo-controlled trial. Neurology, 74(5), 413-420. doi: 10.1212/WNL.0b013e3181ccc6ef Journal - Research Article
Malhotra, B. K., Crownover, P. H., LaBadie, R., Glue, P., & MacDiarmid, S. A. (2010). The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosing. European Journal of Clinical Pharmacology, 66(2), 171-176. doi: 10.1007/s00228-009-0748-y Journal - Research Article
Andrews, E., Glue, P., Fang, J., Crownover, P., Tressler, R., & Damle, B. (2010). Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir. British Journal of Clinical Pharmacology, 69(1), 51-57. doi: 10.1111/j.1365-2125.2009.03546.x Journal - Research Article
Glue, P., Henry, M., Bolo, N., Villafuerte, R., LaBadie, R., Schlamm, H., … Damle, B. (2009). Voriconazole brain penetration assessed by fluorine-magnetic resonance spectroscopy 19F MRS. In D. Hay & S. Ngo (Eds.), Proceedings of the 43rd Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. 14. ASCEPT. [Abstract] Conference Contribution - Published proceedings: Abstract
Damle, B. D., Uderman, H., Biswas, P., Crownover, P., Lin, C., & Glue, P. (2009). Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite. British Journal of Clinical Pharmacology, 68(5), 682-689. doi: 10.1111/j.1365-2125.2009.03499.x Journal - Research Article
Damle, B., Fosser, C., Ito, K., Tran, A., Clax, P., Uderman, H., & Glue, P. (2009). Effects of standard and supratherapeutic doses of nelfinavir on cardiac repolarization: A thorough QT study. Journal of Clinical Pharmacology, 49(3), 291-300. doi: 10.1177/0091270008329551 Journal - Research Article
Glue, P. (2009, October). Novel treatments to enhance learning in intellectual disability. Keynote presentation at the Royal Australian and New Zealand College of Psychiatrists' New Zealand Conference, Rotorua, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs
Glue, P., & Patterson, T. (2009). Can drug treatments enhance learning in subjects with intellectual disability? Australian & New Zealand Journal of Psychiatry, 43(10), 899-904. doi: 10.1080/00048670903179178 Journal - Research Article
Lee, S., Malhotra, B., Creanga, D., Carlsson, M., & Glue, P. (2009). A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder. BMC Medical Research Methodology, 9, 55. doi: 10.1186/1471-2288-9-55 Journal - Research Article
Gandelman, K., Alderman, J. A., Glue, P., Lombardo, I., LaBadie, R. R., Versavel, M., & Preskorn, S. H. (2009). The impact of calories and fat content of meals on oral ziprasidone absorption: A randomized, open-label, crossover trial. Journal of Clinical Psychiatry, 70(1), 58-62. Journal - Research Article
Glue, P. (2009, September). Enhancing learning in intellectual disability: Scientific advances and implications for new treatments. University of Otago, Dunedin, New Zealand. [Inaugural Professorial Lecture]. Other Research Output
Citrome, L., Yang, R., Glue, P., & Karayal, O. N. (2009). Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: A post-hoc analysis of 4 fixed-dose randomized clinical trials. Schizophrenia Research, 111(1-3), 39-45. Journal - Research Article
Malhotra, B. K., & Glue, P. (2008). [Response to ″Feedback to Tolterodine QT″]. Clinical Pharmacology & Therapeutics, 83(2), 233. doi: 10.1038/sj.clpt.6100370 Journal - Research Other
El-Tahtawy, A., Glue, P., Andrews, E. N., Mardekian, J., Amsden, G. W., & Knirsch, C. A. (2008). The effect of azithromycin on ivermectin pharmacokinetics: A population pharmacokinetic model analysis. PLoS Neglected Tropical Diseases, 2(5), e236. Retrieved from http://www.plosntds.org/article/info%3Adoi%2F10.1371%2Fjournal.pntd.0000236 Journal - Research Article
Damle, B., LaBadie, R., Crownover, P., & Glue, P. (2008). Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers. British Journal of Clinical Pharmacology, 65(4), 523-530. doi: 10.1111/j.1365-2125.2007.03085.x Journal - Research Article
Fang, A. F., Damle, B. D., LaBadie, R. R., Crownover, P. H., Hewlett, Jr, D., & Glue, P. W. (2008). Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects. Pharmacotherapy, 28(1), 42-50. Journal - Research Article
Andrews, E., Damle, B. D., Fang, A., Forster, G., Crownover, P., LaBadie, R., & Glue, P. (2008). Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects. British Journal of Clinical Pharmacology, 65(4), 531-539. doi: 10.1111/j.1365-2125.2007.03084.x Journal - Research Article
Lalonde, R. L., Kowalski, K. G., Hutmacher, M. M., Ewy, W., Nichols, D. J., Milligan, P. A., … Glue, P., … Miller, R. (2007). Model-based drug development. Clinical Pharmacology & Therapeutics, 82(1), 21-32. doi: 10.1038/sj.clpt.6100235 Journal - Research Other
Parker, J. D., Bart, B. A., Webb, D. J., Koren, M. J., Siegel, R. L., Wang, H., … Glue, P. (2007). Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: A double-blind, placebo-controlled, randomized, crossover trial. Critical Care Medicine, 35(8), 1863-1868. doi: 10.1097/01.CCM.0000269371.70738.30 Journal - Research Article
Miceli, J. J., Glue, P., Alderman, J., & Wilner, K. (2007). The effect of food on the absorption of oral ziprasidone. Psychopharmacology Bulletin, 40(3), 58-68. Journal - Research Article
Malhotra, B. K., Glue, P., Sweeney, K., Anziano, R., Mancuso, J., & Wicker, P. (2007). Thorough QT study with recommended and supratherapeutic doses of tolterodine. Clinical Pharmacology & Therapeutics, 81(3), 377-385. doi: 10.1038/sj.clpt.6100089 Journal - Research Article
Amsden, G. W., Gregory, T. B., Michalak, C. A., Glue, P., & Knirsch, C. A. (2007). Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers. American Journal of Tropical Medicine & Hygiene, 76(6), 1153-1157. Journal - Research Article
Glue, P., Fang, A., Gandelman, K., & Klee, B. (2006). Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers. American Journal of Therapeutics, 13(5), 418-422. doi: 10.1097/01.mjt.0000182358.63457.48 Journal - Research Article
Chung, M., Calcagni, A., Glue, P., & Bramson, C. (2006). Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet. Journal of Clinical Pharmacology, 46(9), 1030-1037. doi: 10.1177/0091270006291031 Journal - Research Article
Wilson, S. J., Glue, P., Coupland, N. J., Bell, C. J., & Nutt, D. J. (1998). Effect on sleep of lithium augmentation of antidepressants in resistant depression. Journal of Psychopharmacology, 12(3A), (pp. A23). doi: 10.1177/0269881198012003021 Conference Contribution - Published proceedings: Abstract